Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma

ConclusionsDecreased NLR values after treatment using pazopanib may predict high efficacy and favorable outcomes among patients with advanced soft-tissue sarcoma.

http://link.springer.com/10.1007/s10147-017-1199-6

Source: International Journal of Clinical Oncology - October 31, 2017 Category: Cancer & Oncology Source Type: research